CDK9-IN-31

• Description:

  CDK9-IN-31 (Compound Z1) is a CDK9 inhibitor that inhibits cancer cell growth. CDK9-IN-31 has the potential to be developed as an anticancer agent[1].

• UNSPSC:

  12352005

• Target:

  CDK

• Type:

  Reference compound

• Related Pathways:

  Cell Cycle/DNA Damage

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/cdk9-in-31.html

• Solubility:

  10 mM in DMSO

• Smiles:

  OC[C@@H](C)N[C@@H](CC1)CC[C@H]1NC2=CC(C3=CSC(NCC4(CCOCC4)C#N)=N3)=C(Cl)C=N2

• Molecular Formula:

  C24H33ClN6O2S

• Molecular Weight:

  505.08

• References & Citations:

  [1]Fusheng Zhou, et al. CDK9 inhibitor and preparation method and application thereof. Patent CN116496267A.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [2991074-93-0]